The question of whether a serum "works topically" is largely a function of whether its molecules ever cross the skin barrier
However, the body can convert cyanocobalamin into the coenzyme forms methylcobalamin and adenosylcobalamin
This resulted in a pooled incidence rate of 2.1 per 1,000 patient years for the GLP-1 receptor agonists compared with 1.5 per 1,000 patient years for the comparators
PV1 BSO resistant (BSOr) mutants evolved readily during passaging of the virus in the presence of BSO
Phospholipase D can catalyze the conversion of lecithin to choline, which is a reversible transformation (Zeisel et al., 2003) contain several choline compounds (phosphatidylcholine, phosphocholine, sphingomyelin, etc
Symptoms can include difficulty breathing, hives, and swelling of the face, lips, tongue, or throat [12]